Clinical Trial Update: Hemopatch Implication After Axillary Dissection for Breast Cancer [NA]

View source ↗

Summary

A Hemopatch-based clinical study following axillary dissection for breast cancer is noted. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hemopatch

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer | NA | Status: NOT_YET_RECRUITING